Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing

被引:0
|
作者
Tao, Lixin [1 ,2 ]
Han, Lili [3 ]
Li, Xia [1 ,2 ]
Gao, Qi [1 ,2 ]
Pan, Lei [1 ,2 ]
Wu, Lijuan [1 ,2 ]
Luo, Yanxia [1 ,2 ]
Wang, Wei [1 ,2 ,4 ]
Zheng, Zihe [1 ,2 ]
Guo, Xiuhua [1 ,2 ]
机构
[1] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China
[2] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China
[3] Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China
[4] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia
来源
BMC PUBLIC HEALTH | 2014年 / 14卷
关键词
Cervical cancer; Screening program; Risk factor; High-grade cervical squamous intraepithelial lesions; HUMAN-PAPILLOMAVIRUS INFECTION; ORAL-CONTRACEPTIVE USE; COOKING OIL FUMES; TRICHOMONAS-VAGINALIS; INTRAEPITHELIAL NEOPLASM; GENITAL WARTS; WOMEN; ASSOCIATION; INFLAMMATION; PREVENTION;
D O I
10.1186/1471-2458-14-1185
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Cervical cancer is the second most common cancer and cause of cancer-related death for women worldwide. The aims of this study were to investigate the prevalence of cervical neoplasia and examine factors associated with high-grade cervical squamous intraepithelial lesions (HSIL) among women taking part in a cervical cancer screening program in Beijing. Methods: Women aged 25-65 years were screened using the ThinPrep cytologic test and gynecologic examination. Univariate and multivariate logistic regressions were conducted to investigate factors associated with HSIL. Results: Among 728,704 women screened, the prevalence of cervical intraepithelial neoplasia (CIN) I, II, III was 50.2, 34.0, and 36.4 per 100,000, respectively. Prevalence of cervical cancer was 12.2 per 100,000. Risk factors for HSIL included being in age group of 46-55 years (adjusted odds ratio [aOR] = 1.15, 95% CI: 1.07-1.44, compared with the 25-35 age group), bleeding after intercourse (aOR = 2.08, 95% CI: 1.40-3.10), and presence of trichomonas vaginalis infection (aOR = 2.62, 95% CI: 1.35-5.07), cervical inflammation (aOR = 4.22, 95% CI: 3.39-5.26), and genital warts (aOR = 3.89, 95% CI: 2.54-7.70). High education level (college and above compared with junior middle school or lower) was found to be protective (aOR = 0.79, 95% CI: 0.37-0.90). Conclusions: The prevalence of cervical neoplasia is relatively high in Beijing. Women aged 46-55 years, those with a lower education level, those reporting bleeding after intercourse, and those affected by Trichomonas vaginalis infection, cervical inflammation and genital warts are at higher risk for HSIL. Particular efforts should be made to ensure these women are included in cervical cancer screening programs.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women
    Pereira Teixeira, Nara Chartuni
    Labanca Araujo, Angela Cristina
    Correa, Christine Miranda
    da Costa Lodi, Claudia Teixeira
    Miranda Lima, Maria Ines
    Carvalho, Nara de Oliveira
    del Castillo, Dora Mendez
    Melo, Victor Hugo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (02) : 164 - 169
  • [32] Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program
    Wang, Jiangrong
    Elfstrom, K. Miriam
    Andrae, Bengt
    Kleppe, Sara Nordqvist
    Ploner, Alexander
    Lei, Jiayao
    Dillner, Joakim
    Sundstrom, Karin
    Sparen, Par
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (05) : 1230 - 1240
  • [33] HPV infection and cervical neoplasia: associated risk factors
    Ribeiro, Andrea Alves
    Costa, Maria Cecilia
    Figueiredo Alves, Rosane Ribeiro
    Villa, Luisa Lina
    Saddi, Vera Aparecida
    dos Santos Carneiro, Megmar Aparecida
    Zeferino, Luiz Carlos
    Rabelo-Santos, Silvia Helena
    INFECTIOUS AGENTS AND CANCER, 2015, 10
  • [34] A critical assessment of screening methods for cervical neoplasia
    Sankaranarayanan, R
    Gaffikin, L
    Jacob, M
    Sellors, J
    Robles, S
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 89 : S4 - S12
  • [35] Prevalence and Correlates of Human Papillomavirus Genotypes Among Patients With Cervical Cancer and Cervical Intraepithelial Neoplasia 3 in Israel
    Bassal, Ravit
    Rosin, Lia Supino
    Schvimer, Michael
    Schejter, Eduardo
    Ozeryansky, Bella
    Kulik, Svetlana
    Bachar, Rachel
    Shapira, Hagit
    Sandbank, Judith
    Cohen, Daniel
    Keinan-Boker, Lital
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2015, 19 (02) : 161 - 164
  • [36] Human papillomavirus Posttreatment Clearance Time in Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer
    Abudurexiti, Guligeina
    Tuerxun, Gulixian
    Abulizi, Guzhalinuer
    Mijiti, Patiman
    Aierken, Kailibinuer
    Maimaiti, Anaerguli
    Li, Hua
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2020, 24 (01) : 34 - 37
  • [37] Postoperative prognosis and risk factors in patients with early cervical cancer
    Ren, Rui
    Zhou, Meiying
    Wu, Jian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10703 - 10708
  • [38] Cervical cancer screening program in Thimphu, Bhutan: population coverage and characteristics associated with screening attendance
    Baussano, Iacopo
    Tshomo, Ugyen
    Clifford, Gary M.
    Tenet, Vanessa
    Tshokey, Tshokey
    Franceschi, Silvia
    BMC WOMENS HEALTH, 2014, 14
  • [39] RISK FACTORS OF INVASIVE CERVICAL CANCER IN MOROCCO
    Meftah El Khair, M.
    Ait Mhand, R.
    El Mzibri, M.
    Ennaji, M. M.
    CELLULAR AND MOLECULAR BIOLOGY, 2009, 55 : 1175 - 1185
  • [40] Why does cervical cancer occur in a state-of-the-art screening program?
    Castle, Philip E.
    Kinney, Walter K.
    Cheung, Li C.
    Gage, Julia C.
    Fetterman, Barbara
    Poitras, Nancy E.
    Lorey, Thomas S.
    Wentzensen, Nicolas
    Befano, Brian
    Schussler, John
    Katki, Hormuzd A.
    Schiffman, Mark
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 546 - 553